世界の気管支肺異形成症（BPD）疫学市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Bronchopulmonary Dysplasia (BPD) Epidemiology Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-3945 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、気管支肺異形成症（BPD）疫学の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ステロイド、界面活性剤、気管支拡張薬、ビタミンA、メチルキサンチン、利尿薬、抗生物質）、用途別市場規模（病院、薬局、研究所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・気管支肺異形成症（BPD）疫学の市場動向 ・企業の競争状況、市場シェア ・気管支肺異形成症（BPD）疫学の種類別市場規模と予測2016-2027（ステロイド、界面活性剤、気管支拡張薬、ビタミンA、メチルキサンチン、利尿薬、抗生物質） ・気管支肺異形成症（BPD）疫学の用途別市場規模と予測2016-2027（病院、薬局、研究所、その他） ・気管支肺異形成症（BPD）疫学の北米市場規模2016-2027（アメリカ、カナダ） ・気管支肺異形成症（BPD）疫学の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・気管支肺異形成症（BPD）疫学のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・気管支肺異形成症（BPD）疫学の中南米市場規模2016-2027（メキシコ、ブラジル） ・気管支肺異形成症（BPD）疫学の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Medipost、Windtree Therapeutics、Therabron Therapeutics、Takeda、Airway Therapeutics, LLC、Chiesi Farmaceutici SpA、Insmed Incorporated） ・結論

Market Analysis and Insights: Global Bronchopulmonary Dysplasia (BPD) Epidemiology Market
The global Bronchopulmonary Dysplasia (BPD) Epidemiology market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Bronchopulmonary Dysplasia (BPD) Epidemiology market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Bronchopulmonary Dysplasia (BPD) Epidemiology market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Bronchopulmonary Dysplasia (BPD) Epidemiology market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Bronchopulmonary Dysplasia (BPD) Epidemiology market.

Global Bronchopulmonary Dysplasia (BPD) Epidemiology Scope and Market Size
Bronchopulmonary Dysplasia (BPD) Epidemiology market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Bronchopulmonary Dysplasia (BPD) Epidemiology market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Steroids
Surfactants
Bronchodilators
Vitamin A
Methylxanthines
Diuretics
Antibiotics

Segment by Application
Hospital
Pharmacy
Research
Other

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Medipost
Windtree Therapeutics
Therabron Therapeutics
Takeda
Airway Therapeutics, LLC
Chiesi Farmaceutici SpA
Insmed Incorporated

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Bronchopulmonary Dysplasia (BPD) Epidemiology Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Steroids
1.2.3 Surfactants
1.2.4 Bronchodilators
1.2.5 Vitamin A
1.2.6 Methylxanthines
1.2.7 Diuretics
1.2.8 Antibiotics
1.3 Market by Application
1.3.1 Global Bronchopulmonary Dysplasia (BPD) Epidemiology Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Pharmacy
1.3.4 Research
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Bronchopulmonary Dysplasia (BPD) Epidemiology Market Perspective (2016-2027)
2.2 Bronchopulmonary Dysplasia (BPD) Epidemiology Growth Trends by Regions
2.2.1 Bronchopulmonary Dysplasia (BPD) Epidemiology Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Bronchopulmonary Dysplasia (BPD) Epidemiology Historic Market Share by Regions (2016-2021)
2.2.3 Bronchopulmonary Dysplasia (BPD) Epidemiology Forecasted Market Size by Regions (2022-2027)
2.3 Bronchopulmonary Dysplasia (BPD) Epidemiology Industry Dynamic
2.3.1 Bronchopulmonary Dysplasia (BPD) Epidemiology Market Trends
2.3.2 Bronchopulmonary Dysplasia (BPD) Epidemiology Market Drivers
2.3.3 Bronchopulmonary Dysplasia (BPD) Epidemiology Market Challenges
2.3.4 Bronchopulmonary Dysplasia (BPD) Epidemiology Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Bronchopulmonary Dysplasia (BPD) Epidemiology Players by Revenue
3.1.1 Global Top Bronchopulmonary Dysplasia (BPD) Epidemiology Players by Revenue (2016-2021)
3.1.2 Global Bronchopulmonary Dysplasia (BPD) Epidemiology Revenue Market Share by Players (2016-2021)
3.2 Global Bronchopulmonary Dysplasia (BPD) Epidemiology Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Bronchopulmonary Dysplasia (BPD) Epidemiology Revenue
3.4 Global Bronchopulmonary Dysplasia (BPD) Epidemiology Market Concentration Ratio
3.4.1 Global Bronchopulmonary Dysplasia (BPD) Epidemiology Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Bronchopulmonary Dysplasia (BPD) Epidemiology Revenue in 2020
3.5 Bronchopulmonary Dysplasia (BPD) Epidemiology Key Players Head office and Area Served
3.6 Key Players Bronchopulmonary Dysplasia (BPD) Epidemiology Product Solution and Service
3.7 Date of Enter into Bronchopulmonary Dysplasia (BPD) Epidemiology Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Bronchopulmonary Dysplasia (BPD) Epidemiology Breakdown Data by Type
4.1 Global Bronchopulmonary Dysplasia (BPD) Epidemiology Historic Market Size by Type (2016-2021)
4.2 Global Bronchopulmonary Dysplasia (BPD) Epidemiology Forecasted Market Size by Type (2022-2027)

5 Bronchopulmonary Dysplasia (BPD) Epidemiology Breakdown Data by Application
5.1 Global Bronchopulmonary Dysplasia (BPD) Epidemiology Historic Market Size by Application (2016-2021)
5.2 Global Bronchopulmonary Dysplasia (BPD) Epidemiology Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Bronchopulmonary Dysplasia (BPD) Epidemiology Market Size (2016-2027)
6.2 North America Bronchopulmonary Dysplasia (BPD) Epidemiology Market Size by Type
6.2.1 North America Bronchopulmonary Dysplasia (BPD) Epidemiology Market Size by Type (2016-2021)
6.2.2 North America Bronchopulmonary Dysplasia (BPD) Epidemiology Market Size by Type (2022-2027)
6.2.3 North America Bronchopulmonary Dysplasia (BPD) Epidemiology Market Size by Type (2016-2027)
6.3 North America Bronchopulmonary Dysplasia (BPD) Epidemiology Market Size by Application
6.3.1 North America Bronchopulmonary Dysplasia (BPD) Epidemiology Market Size by Application (2016-2021)
6.3.2 North America Bronchopulmonary Dysplasia (BPD) Epidemiology Market Size by Application (2022-2027)
6.3.3 North America Bronchopulmonary Dysplasia (BPD) Epidemiology Market Size by Application (2016-2027)
6.4 North America Bronchopulmonary Dysplasia (BPD) Epidemiology Market Size by Country
6.4.1 North America Bronchopulmonary Dysplasia (BPD) Epidemiology Market Size by Country (2016-2021)
6.4.2 North America Bronchopulmonary Dysplasia (BPD) Epidemiology Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Bronchopulmonary Dysplasia (BPD) Epidemiology Market Size (2016-2027)
7.2 Europe Bronchopulmonary Dysplasia (BPD) Epidemiology Market Size by Type
7.2.1 Europe Bronchopulmonary Dysplasia (BPD) Epidemiology Market Size by Type (2016-2021)
7.2.2 Europe Bronchopulmonary Dysplasia (BPD) Epidemiology Market Size by Type (2022-2027)
7.2.3 Europe Bronchopulmonary Dysplasia (BPD) Epidemiology Market Size by Type (2016-2027)
7.3 Europe Bronchopulmonary Dysplasia (BPD) Epidemiology Market Size by Application
7.3.1 Europe Bronchopulmonary Dysplasia (BPD) Epidemiology Market Size by Application (2016-2021)
7.3.2 Europe Bronchopulmonary Dysplasia (BPD) Epidemiology Market Size by Application (2022-2027)
7.3.3 Europe Bronchopulmonary Dysplasia (BPD) Epidemiology Market Size by Application (2016-2027)
7.4 Europe Bronchopulmonary Dysplasia (BPD) Epidemiology Market Size by Country
7.4.1 Europe Bronchopulmonary Dysplasia (BPD) Epidemiology Market Size by Country (2016-2021)
7.4.2 Europe Bronchopulmonary Dysplasia (BPD) Epidemiology Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Bronchopulmonary Dysplasia (BPD) Epidemiology Market Size (2016-2027)
8.2 Asia-Pacific Bronchopulmonary Dysplasia (BPD) Epidemiology Market Size by Type
8.2.1 Asia-Pacific Bronchopulmonary Dysplasia (BPD) Epidemiology Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Bronchopulmonary Dysplasia (BPD) Epidemiology Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Bronchopulmonary Dysplasia (BPD) Epidemiology Market Size by Type (2016-2027)
8.3 Asia-Pacific Bronchopulmonary Dysplasia (BPD) Epidemiology Market Size by Application
8.3.1 Asia-Pacific Bronchopulmonary Dysplasia (BPD) Epidemiology Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Bronchopulmonary Dysplasia (BPD) Epidemiology Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Bronchopulmonary Dysplasia (BPD) Epidemiology Market Size by Application (2016-2027)
8.4 Asia-Pacific Bronchopulmonary Dysplasia (BPD) Epidemiology Market Size by Region
8.4.1 Asia-Pacific Bronchopulmonary Dysplasia (BPD) Epidemiology Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Bronchopulmonary Dysplasia (BPD) Epidemiology Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Bronchopulmonary Dysplasia (BPD) Epidemiology Market Size (2016-2027)
9.2 Latin America Bronchopulmonary Dysplasia (BPD) Epidemiology Market Size by Type
9.2.1 Latin America Bronchopulmonary Dysplasia (BPD) Epidemiology Market Size by Type (2016-2021)
9.2.2 Latin America Bronchopulmonary Dysplasia (BPD) Epidemiology Market Size by Type (2022-2027)
9.2.3 Latin America Bronchopulmonary Dysplasia (BPD) Epidemiology Market Size by Type (2016-2027)
9.3 Latin America Bronchopulmonary Dysplasia (BPD) Epidemiology Market Size by Application
9.3.1 Latin America Bronchopulmonary Dysplasia (BPD) Epidemiology Market Size by Application (2016-2021)
9.3.2 Latin America Bronchopulmonary Dysplasia (BPD) Epidemiology Market Size by Application (2022-2027)
9.3.3 Latin America Bronchopulmonary Dysplasia (BPD) Epidemiology Market Size by Application (2016-2027)
9.4 Latin America Bronchopulmonary Dysplasia (BPD) Epidemiology Market Size by Country
9.4.1 Latin America Bronchopulmonary Dysplasia (BPD) Epidemiology Market Size by Country (2016-2021)
9.4.2 Latin America Bronchopulmonary Dysplasia (BPD) Epidemiology Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Bronchopulmonary Dysplasia (BPD) Epidemiology Market Size (2016-2027)
10.2 Middle East & Africa Bronchopulmonary Dysplasia (BPD) Epidemiology Market Size by Type
10.2.1 Middle East & Africa Bronchopulmonary Dysplasia (BPD) Epidemiology Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Bronchopulmonary Dysplasia (BPD) Epidemiology Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Bronchopulmonary Dysplasia (BPD) Epidemiology Market Size by Type (2016-2027)
10.3 Middle East & Africa Bronchopulmonary Dysplasia (BPD) Epidemiology Market Size by Application
10.3.1 Middle East & Africa Bronchopulmonary Dysplasia (BPD) Epidemiology Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Bronchopulmonary Dysplasia (BPD) Epidemiology Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Bronchopulmonary Dysplasia (BPD) Epidemiology Market Size by Application (2016-2027)
10.4 Middle East & Africa Bronchopulmonary Dysplasia (BPD) Epidemiology Market Size by Country
10.4.1 Middle East & Africa Bronchopulmonary Dysplasia (BPD) Epidemiology Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Bronchopulmonary Dysplasia (BPD) Epidemiology Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Medipost
11.1.1 Medipost Company Details
11.1.2 Medipost Business Overview
11.1.3 Medipost Bronchopulmonary Dysplasia (BPD) Epidemiology Introduction
11.1.4 Medipost Revenue in Bronchopulmonary Dysplasia (BPD) Epidemiology Business (2016-2021)
11.1.5 Medipost Recent Development
11.2 Windtree Therapeutics
11.2.1 Windtree Therapeutics Company Details
11.2.2 Windtree Therapeutics Business Overview
11.2.3 Windtree Therapeutics Bronchopulmonary Dysplasia (BPD) Epidemiology Introduction
11.2.4 Windtree Therapeutics Revenue in Bronchopulmonary Dysplasia (BPD) Epidemiology Business (2016-2021)
11.2.5 Windtree Therapeutics Recent Development
11.3 Therabron Therapeutics
11.3.1 Therabron Therapeutics Company Details
11.3.2 Therabron Therapeutics Business Overview
11.3.3 Therabron Therapeutics Bronchopulmonary Dysplasia (BPD) Epidemiology Introduction
11.3.4 Therabron Therapeutics Revenue in Bronchopulmonary Dysplasia (BPD) Epidemiology Business (2016-2021)
11.3.5 Therabron Therapeutics Recent Development
11.4 Takeda
11.4.1 Takeda Company Details
11.4.2 Takeda Business Overview
11.4.3 Takeda Bronchopulmonary Dysplasia (BPD) Epidemiology Introduction
11.4.4 Takeda Revenue in Bronchopulmonary Dysplasia (BPD) Epidemiology Business (2016-2021)
11.4.5 Takeda Recent Development
11.5 Airway Therapeutics, LLC
11.5.1 Airway Therapeutics, LLC Company Details
11.5.2 Airway Therapeutics, LLC Business Overview
11.5.3 Airway Therapeutics, LLC Bronchopulmonary Dysplasia (BPD) Epidemiology Introduction
11.5.4 Airway Therapeutics, LLC Revenue in Bronchopulmonary Dysplasia (BPD) Epidemiology Business (2016-2021)
11.5.5 Airway Therapeutics, LLC Recent Development
11.6 Chiesi Farmaceutici SpA
11.6.1 Chiesi Farmaceutici SpA Company Details
11.6.2 Chiesi Farmaceutici SpA Business Overview
11.6.3 Chiesi Farmaceutici SpA Bronchopulmonary Dysplasia (BPD) Epidemiology Introduction
11.6.4 Chiesi Farmaceutici SpA Revenue in Bronchopulmonary Dysplasia (BPD) Epidemiology Business (2016-2021)
11.6.5 Chiesi Farmaceutici SpA Recent Development
11.7 Insmed Incorporated
11.7.1 Insmed Incorporated Company Details
11.7.2 Insmed Incorporated Business Overview
11.7.3 Insmed Incorporated Bronchopulmonary Dysplasia (BPD) Epidemiology Introduction
11.7.4 Insmed Incorporated Revenue in Bronchopulmonary Dysplasia (BPD) Epidemiology Business (2016-2021)
11.7.5 Insmed Incorporated Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Bronchopulmonary Dysplasia (BPD) Epidemiology Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Steroids
Table 3. Key Players of Surfactants
Table 4. Key Players of Bronchodilators
Table 5. Key Players of Vitamin A
Table 6. Key Players of Methylxanthines
Table 7. Key Players of Diuretics
Table 8. Key Players of Antibiotics
Table 9. Global Bronchopulmonary Dysplasia (BPD) Epidemiology Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Bronchopulmonary Dysplasia (BPD) Epidemiology Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 11. Global Bronchopulmonary Dysplasia (BPD) Epidemiology Market Size by Regions (2016-2021) & (US$ Million)
Table 12. Global Bronchopulmonary Dysplasia (BPD) Epidemiology Market Share by Regions (2016-2021)
Table 13. Global Bronchopulmonary Dysplasia (BPD) Epidemiology Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 14. Global Bronchopulmonary Dysplasia (BPD) Epidemiology Market Share by Regions (2022-2027)
Table 15. Bronchopulmonary Dysplasia (BPD) Epidemiology Market Trends
Table 16. Bronchopulmonary Dysplasia (BPD) Epidemiology Market Drivers
Table 17. Bronchopulmonary Dysplasia (BPD) Epidemiology Market Challenges
Table 18. Bronchopulmonary Dysplasia (BPD) Epidemiology Market Restraints
Table 19. Global Bronchopulmonary Dysplasia (BPD) Epidemiology Revenue by Players (2016-2021) & (US$ Million)
Table 20. Global Bronchopulmonary Dysplasia (BPD) Epidemiology Market Share by Players (2016-2021)
Table 21. Global Top Bronchopulmonary Dysplasia (BPD) Epidemiology Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bronchopulmonary Dysplasia (BPD) Epidemiology as of 2020)
Table 22. Ranking of Global Top Bronchopulmonary Dysplasia (BPD) Epidemiology Companies by Revenue (US$ Million) in 2020
Table 23. Global 5 Largest Players Market Share by Bronchopulmonary Dysplasia (BPD) Epidemiology Revenue (CR5 and HHI) & (2016-2021)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Bronchopulmonary Dysplasia (BPD) Epidemiology Product Solution and Service
Table 26. Date of Enter into Bronchopulmonary Dysplasia (BPD) Epidemiology Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Bronchopulmonary Dysplasia (BPD) Epidemiology Market Size by Type (2016-2021) (US$ Million)
Table 29. Global Bronchopulmonary Dysplasia (BPD) Epidemiology Revenue Market Share by Type (2016-2021)
Table 30. Global Bronchopulmonary Dysplasia (BPD) Epidemiology Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 31. Global Bronchopulmonary Dysplasia (BPD) Epidemiology Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 32. Global Bronchopulmonary Dysplasia (BPD) Epidemiology Market Size Share by Application (2016-2021) & (US$ Million)
Table 33. Global Bronchopulmonary Dysplasia (BPD) Epidemiology Revenue Market Share by Application (2016-2021)
Table 34. Global Bronchopulmonary Dysplasia (BPD) Epidemiology Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 35. Global Bronchopulmonary Dysplasia (BPD) Epidemiology Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 36. North America Bronchopulmonary Dysplasia (BPD) Epidemiology Market Size by Type (2016-2021) (US$ Million)
Table 37. North America Bronchopulmonary Dysplasia (BPD) Epidemiology Market Size by Type (2022-2027) & (US$ Million)
Table 38. North America Bronchopulmonary Dysplasia (BPD) Epidemiology Market Size by Application (2016-2021) (US$ Million)
Table 39. North America Bronchopulmonary Dysplasia (BPD) Epidemiology Market Size by Application (2022-2027) & (US$ Million)
Table 40. North America Bronchopulmonary Dysplasia (BPD) Epidemiology Market Size by Country (2016-2021) & (US$ Million)
Table 41. North America Bronchopulmonary Dysplasia (BPD) Epidemiology Market Size by Country (2022-2027) & (US$ Million)
Table 42. Europe Bronchopulmonary Dysplasia (BPD) Epidemiology Market Size by Type (2016-2021) (US$ Million)
Table 43. Europe Bronchopulmonary Dysplasia (BPD) Epidemiology Market Size by Type (2022-2027) & (US$ Million)
Table 44. Europe Bronchopulmonary Dysplasia (BPD) Epidemiology Market Size by Application (2016-2021) (US$ Million)
Table 45. Europe Bronchopulmonary Dysplasia (BPD) Epidemiology Market Size by Application (2022-2027) & (US$ Million)
Table 46. Europe Bronchopulmonary Dysplasia (BPD) Epidemiology Market Size by Country (2016-2021) & (US$ Million)
Table 47. Europe Bronchopulmonary Dysplasia (BPD) Epidemiology Market Size by Country (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Bronchopulmonary Dysplasia (BPD) Epidemiology Market Size by Type (2016-2021) (US$ Million)
Table 49. Asia-Pacific Bronchopulmonary Dysplasia (BPD) Epidemiology Market Size by Type (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Bronchopulmonary Dysplasia (BPD) Epidemiology Market Size by Application (2016-2021) (US$ Million)
Table 51. Asia-Pacific Bronchopulmonary Dysplasia (BPD) Epidemiology Market Size by Application (2022-2027) & (US$ Million)
Table 52. Asia-Pacific Bronchopulmonary Dysplasia (BPD) Epidemiology Market Size by Region (2016-2021) & (US$ Million)
Table 53. Asia-Pacific Bronchopulmonary Dysplasia (BPD) Epidemiology Market Size by Region (2022-2027) & (US$ Million)
Table 54. Latin America Bronchopulmonary Dysplasia (BPD) Epidemiology Market Size by Type (2016-2021) (US$ Million)
Table 55. Latin America Bronchopulmonary Dysplasia (BPD) Epidemiology Market Size by Type (2022-2027) & (US$ Million)
Table 56. Latin America Bronchopulmonary Dysplasia (BPD) Epidemiology Market Size by Application (2016-2021) (US$ Million)
Table 57. Latin America Bronchopulmonary Dysplasia (BPD) Epidemiology Market Size by Application (2022-2027) & (US$ Million)
Table 58. Latin America Bronchopulmonary Dysplasia (BPD) Epidemiology Market Size by Country (2016-2021) & (US$ Million)
Table 59. Latin America Bronchopulmonary Dysplasia (BPD) Epidemiology Market Size by Country (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Bronchopulmonary Dysplasia (BPD) Epidemiology Market Size by Type (2016-2021) (US$ Million)
Table 61. Middle East & Africa Bronchopulmonary Dysplasia (BPD) Epidemiology Market Size by Type (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Bronchopulmonary Dysplasia (BPD) Epidemiology Market Size by Application (2016-2021) (US$ Million)
Table 63. Middle East & Africa Bronchopulmonary Dysplasia (BPD) Epidemiology Market Size by Application (2022-2027) & (US$ Million)
Table 64. Middle East & Africa Bronchopulmonary Dysplasia (BPD) Epidemiology Market Size by Country (2016-2021) & (US$ Million)
Table 65. Middle East & Africa Bronchopulmonary Dysplasia (BPD) Epidemiology Market Size by Country (2022-2027) & (US$ Million)
Table 66. Medipost Company Details
Table 67. Medipost Business Overview
Table 68. Medipost Bronchopulmonary Dysplasia (BPD) Epidemiology Product
Table 69. Medipost Revenue in Bronchopulmonary Dysplasia (BPD) Epidemiology Business (2016-2021) & (US$ Million)
Table 70. Medipost Recent Development
Table 71. Windtree Therapeutics Company Details
Table 72. Windtree Therapeutics Business Overview
Table 73. Windtree Therapeutics Bronchopulmonary Dysplasia (BPD) Epidemiology Product
Table 74. Windtree Therapeutics Revenue in Bronchopulmonary Dysplasia (BPD) Epidemiology Business (2016-2021) & (US$ Million)
Table 75. Windtree Therapeutics Recent Development
Table 76. Therabron Therapeutics Company Details
Table 77. Therabron Therapeutics Business Overview
Table 78. Therabron Therapeutics Bronchopulmonary Dysplasia (BPD) Epidemiology Product
Table 79. Therabron Therapeutics Revenue in Bronchopulmonary Dysplasia (BPD) Epidemiology Business (2016-2021) & (US$ Million)
Table 80. Therabron Therapeutics Recent Development
Table 81. Takeda Company Details
Table 82. Takeda Business Overview
Table 83. Takeda Bronchopulmonary Dysplasia (BPD) Epidemiology Product
Table 84. Takeda Revenue in Bronchopulmonary Dysplasia (BPD) Epidemiology Business (2016-2021) & (US$ Million)
Table 85. Takeda Recent Development
Table 86. Airway Therapeutics, LLC Company Details
Table 87. Airway Therapeutics, LLC Business Overview
Table 88. Airway Therapeutics, LLC Bronchopulmonary Dysplasia (BPD) Epidemiology Product
Table 89. Airway Therapeutics, LLC Revenue in Bronchopulmonary Dysplasia (BPD) Epidemiology Business (2016-2021) & (US$ Million)
Table 90. Airway Therapeutics, LLC Recent Development
Table 91. Chiesi Farmaceutici SpA Company Details
Table 92. Chiesi Farmaceutici SpA Business Overview
Table 93. Chiesi Farmaceutici SpA Bronchopulmonary Dysplasia (BPD) Epidemiology Product
Table 94. Chiesi Farmaceutici SpA Revenue in Bronchopulmonary Dysplasia (BPD) Epidemiology Business (2016-2021) & (US$ Million)
Table 95. Chiesi Farmaceutici SpA Recent Development
Table 96. Insmed Incorporated Company Details
Table 97. Insmed Incorporated Business Overview
Table 98. Insmed Incorporated Bronchopulmonary Dysplasia (BPD) Epidemiology Product
Table 99. Insmed Incorporated Revenue in Bronchopulmonary Dysplasia (BPD) Epidemiology Business (2016-2021) & (US$ Million)
Table 100. Insmed Incorporated Recent Development
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Bronchopulmonary Dysplasia (BPD) Epidemiology Market Share by Type: 2020 VS 2027
Figure 2. Steroids Features
Figure 3. Surfactants Features
Figure 4. Bronchodilators Features
Figure 5. Vitamin A Features
Figure 6. Methylxanthines Features
Figure 7. Diuretics Features
Figure 8. Antibiotics Features
Figure 9. Global Bronchopulmonary Dysplasia (BPD) Epidemiology Market Share by Application: 2020 VS 2027
Figure 10. Hospital Case Studies
Figure 11. Pharmacy Case Studies
Figure 12. Research Case Studies
Figure 13. Other Case Studies
Figure 14. Bronchopulmonary Dysplasia (BPD) Epidemiology Report Years Considered
Figure 15. Global Bronchopulmonary Dysplasia (BPD) Epidemiology Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 16. Global Bronchopulmonary Dysplasia (BPD) Epidemiology Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 17. Global Bronchopulmonary Dysplasia (BPD) Epidemiology Market Share by Regions: 2020 VS 2027
Figure 18. Global Bronchopulmonary Dysplasia (BPD) Epidemiology Market Share by Regions (2022-2027)
Figure 19. Global Bronchopulmonary Dysplasia (BPD) Epidemiology Market Share by Players in 2020
Figure 20. Global Top Bronchopulmonary Dysplasia (BPD) Epidemiology Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bronchopulmonary Dysplasia (BPD) Epidemiology as of 2020
Figure 21. The Top 10 and 5 Players Market Share by Bronchopulmonary Dysplasia (BPD) Epidemiology Revenue in 2020
Figure 22. Global Bronchopulmonary Dysplasia (BPD) Epidemiology Revenue Market Share by Type (2016-2021)
Figure 23. Global Bronchopulmonary Dysplasia (BPD) Epidemiology Revenue Market Share by Type (2022-2027)
Figure 24. North America Bronchopulmonary Dysplasia (BPD) Epidemiology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. North America Bronchopulmonary Dysplasia (BPD) Epidemiology Market Share by Type (2016-2027)
Figure 26. North America Bronchopulmonary Dysplasia (BPD) Epidemiology Market Share by Application (2016-2027)
Figure 27. North America Bronchopulmonary Dysplasia (BPD) Epidemiology Market Share by Country (2016-2027)
Figure 28. United States Bronchopulmonary Dysplasia (BPD) Epidemiology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Canada Bronchopulmonary Dysplasia (BPD) Epidemiology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Europe Bronchopulmonary Dysplasia (BPD) Epidemiology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Europe Bronchopulmonary Dysplasia (BPD) Epidemiology Market Share by Type (2016-2027)
Figure 32. Europe Bronchopulmonary Dysplasia (BPD) Epidemiology Market Share by Application (2016-2027)
Figure 33. Europe Bronchopulmonary Dysplasia (BPD) Epidemiology Market Share by Country (2016-2027)
Figure 34. Germany Bronchopulmonary Dysplasia (BPD) Epidemiology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. France Bronchopulmonary Dysplasia (BPD) Epidemiology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. U.K. Bronchopulmonary Dysplasia (BPD) Epidemiology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Italy Bronchopulmonary Dysplasia (BPD) Epidemiology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Russia Bronchopulmonary Dysplasia (BPD) Epidemiology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Nordic Bronchopulmonary Dysplasia (BPD) Epidemiology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Asia-Pacific Bronchopulmonary Dysplasia (BPD) Epidemiology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Asia-Pacific Bronchopulmonary Dysplasia (BPD) Epidemiology Market Share by Type (2016-2027)
Figure 42. Asia-Pacific Bronchopulmonary Dysplasia (BPD) Epidemiology Market Share by Application (2016-2027)
Figure 43. Asia-Pacific Bronchopulmonary Dysplasia (BPD) Epidemiology Market Share by Region (2016-2027)
Figure 44. China Bronchopulmonary Dysplasia (BPD) Epidemiology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Japan Bronchopulmonary Dysplasia (BPD) Epidemiology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. South Korea Bronchopulmonary Dysplasia (BPD) Epidemiology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Southeast Asia Bronchopulmonary Dysplasia (BPD) Epidemiology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. India Bronchopulmonary Dysplasia (BPD) Epidemiology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Australia Bronchopulmonary Dysplasia (BPD) Epidemiology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Latin America Bronchopulmonary Dysplasia (BPD) Epidemiology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Latin America Bronchopulmonary Dysplasia (BPD) Epidemiology Market Share by Type (2016-2027)
Figure 52. Latin America Bronchopulmonary Dysplasia (BPD) Epidemiology Market Share by Application (2016-2027)
Figure 53. Latin America Bronchopulmonary Dysplasia (BPD) Epidemiology Market Share by Country (2016-2027)
Figure 54. Mexico Bronchopulmonary Dysplasia (BPD) Epidemiology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Brazil Bronchopulmonary Dysplasia (BPD) Epidemiology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Middle East & Africa Bronchopulmonary Dysplasia (BPD) Epidemiology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Middle East & Africa Bronchopulmonary Dysplasia (BPD) Epidemiology Market Share by Type (2016-2027)
Figure 58. Middle East & Africa Bronchopulmonary Dysplasia (BPD) Epidemiology Market Share by Application (2016-2027)
Figure 59. Middle East & Africa Bronchopulmonary Dysplasia (BPD) Epidemiology Market Share by Country (2016-2027)
Figure 60. Turkey Bronchopulmonary Dysplasia (BPD) Epidemiology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Saudi Arabia Bronchopulmonary Dysplasia (BPD) Epidemiology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. UAE Bronchopulmonary Dysplasia (BPD) Epidemiology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 63. Medipost Revenue Growth Rate in Bronchopulmonary Dysplasia (BPD) Epidemiology Business (2016-2021)
Figure 64. Windtree Therapeutics Revenue Growth Rate in Bronchopulmonary Dysplasia (BPD) Epidemiology Business (2016-2021)
Figure 65. Therabron Therapeutics Revenue Growth Rate in Bronchopulmonary Dysplasia (BPD) Epidemiology Business (2016-2021)
Figure 66. Takeda Revenue Growth Rate in Bronchopulmonary Dysplasia (BPD) Epidemiology Business (2016-2021)
Figure 67. Airway Therapeutics, LLC Revenue Growth Rate in Bronchopulmonary Dysplasia (BPD) Epidemiology Business (2016-2021)
Figure 68. Chiesi Farmaceutici SpA Revenue Growth Rate in Bronchopulmonary Dysplasia (BPD) Epidemiology Business (2016-2021)
Figure 69. Insmed Incorporated Revenue Growth Rate in Bronchopulmonary Dysplasia (BPD) Epidemiology Business (2016-2021)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed

---